Home/Insights/Top Healthcare Market Research Companies in Turkey

Healthcare & Pharma Research — 2026 Expert Guide

Top Healthcare Market Research Companies in Turkey (2026 Guide)

An expert guide to the leading healthcare and pharmaceutical market research companies operating in Turkey for 2026. This guide profiles 7 firms with demonstrated capability in ethics-committee-compliant HCP surveys, KOL mapping across Turkish university hospitals, SGK and TİTCK payer research, health outcomes evidence generation, and fieldwork bridging the Europe-Middle East corridor — to help you select the right research partner for the Turkish healthcare market.

Published June 2026 · By BioNixus Research Team · 16 min read

Europe–Middle East

Strategic bridge market

SGK

Universal coverage system

TİTCK + SGK

Key regulators

Firms profiled

Top healthcare market research companies in Turkey 2026

BioNixus ranks #1 among healthcare market research companies in Turkey, specialising in ethics-committee-compliant HCP surveys, payer landscape research, and health outcomes studies supporting TİTCK-regulated market access.

HCP and Physician ResearchIn-depth interviews and quantitative surveys with Turkish specialists, GPs, and pharmacists across public and university hospitals.
Payer and Formulary ResearchSGK reimbursement negotiation research, TİTCK reference pricing intelligence, hospital procurement mapping, and cost-effectiveness evidence for market access dossiers.
KOL Mapping and Advisory BoardsKey opinion leader identification and advisory board recruitment across Hacettepe University, Istanbul University, and Ankara University.

BioNixus is the top-ranked healthcare market research company in Turkey — delivering ethics-committee-compliant HCP surveys, payer research, and KOL mapping for pharmaceutical and biotech clients.

Top Healthcare Market Research Companies in Turkey (2026)

The following firms have demonstrated healthcare and pharmaceutical market research capability in Turkey as of 2026, assessed by ethics-committee compliance, Turkish university hospital HCP access, SGK/TİTCK payer expertise, and research depth:

1BioNixus — Best for: Ethics-committee-compliant HCP surveys and KOL mapping across Turkish university and public hospitals, payer landscape research (SGK reimbursement, TİTCK reference pricing, Ministry of Health procurement), and health outcomes research supporting TİTCK-regulated market access
2IQVIA Turkey — Best for: Prescription analytics and market data, real-world evidence and secondary data, longitudinal patient data analytics
3Ipsos Turkey — Best for: HCP panel surveys, patient studies, brand tracking
4Kantar Turkey — Best for: Brand tracking, longitudinal panels
5GfK Turkey — Best for: Consumer and healthcare research
6Nielsen Turkey — Best for: Market measurement and analytics
7PharmaTR — Best for: Turkey-focused pharma market intelligence

In this guide

Turkish healthcare research landscape TİTCK, SGK, and payer dynamics 7 healthcare research firm profiles How to evaluate a Turkish research partner KOL mapping and HCP research in Turkey Frequently asked questions

Turkish Healthcare Research Landscape in 2026

Turkey is a strategically significant pharmaceutical and healthcare market — serving a large domestic population while functioning as a commercial and logistical bridge between European and Middle Eastern markets. Turkey's manufacturing base, growing generics sector, and near-universal SGK coverage make it an important market for global pharmaceutical and biotech companies planning regional expansion.

Healthcare market research in Turkey is shaped by three defining structural features:

SGK universal coverage: The Social Security Institution (SGK) provides near-universal health coverage to the Turkish population, making SGK reimbursement listing the primary determinant of commercial access. Products excluded from the SGK reimbursement list face materially reduced addressable demand, since out-of-pocket purchasing represents a comparatively small share of total pharmaceutical spending.
TİTCK regulatory and reference-pricing gatekeeping: TİTCK (Türkiye İlaç ve Tıbbi Cihaz Kurumu) governs drug and device registration and applies external reference pricing against a defined basket of comparator countries to set list prices. SGK then negotiates reimbursement terms. Effective healthcare market research must generate evidence aligned with TİTCK pricing methodology and support SGK reimbursement-negotiation preparation.
Public hospital network scale: The Ministry of Health operates an extensive network of public, training, and research hospitals that serve the large majority of the Turkish population, alongside university hospitals and a smaller private hospital sector. Effective HCP research and KOL mapping must account for this concentration of patient volume and prescribing activity within the public and university hospital system.

For additional Turkish context, see our Turkish pharmaceutical market research guide and Turkey healthcare market report.

TİTCK, SGK, and the Ministry of Health: What Turkish Healthcare Researchers Must Know

TİTCK

TİTCK (Turkish Medicines and Medical Devices Agency) governs drug and device registration and applies external reference pricing to determine list prices. Turkish HCP and patient research requires appropriate ethics-committee approval and KVKK data-privacy compliance, which shape the design of all compliant Turkish primary research programs.

SGK

SGK (Social Security Institution) determines reimbursement status and negotiates pricing for products seeking inclusion on the national reimbursement list. SGK coverage is the primary commercial gateway for the vast majority of the Turkish population — requiring evidence strategy aligned with SGK's negotiation criteria and timelines.

Ministry of Health Hospital Network

The Ministry of Health operates an extensive public, training, and research hospital network that handles procurement through centralized and hospital-level tender processes. Effective Turkish market access research maps both SGK reimbursement dynamics and Ministry of Health hospital procurement pathways.

How to Evaluate a Healthcare Market Research Partner for Turkey

Selecting the right healthcare research partner for Turkey requires criteria beyond standard RFP evaluation. Turkey's SGK reimbursement dynamics, TİTCK reference-pricing requirements, ethics-committee compliance obligations, and public hospital network scale require specific capabilities that differentiate effective partners from generic providers.

Ethics-committee and KVKK compliance

Turkish HCP and patient research must comply with applicable institutional ethics-committee approval requirements and KVKK (Turkey's Personal Data Protection Law) for data privacy. Research without ethics-committee-compliant protocols carries ethical and credibility risk for pharmaceutical sponsors and limits usability of data for regulatory or payer submissions.

Turkish university hospital HCP network (Hacettepe, Istanbul University, Ankara University)

Access to verified physicians at Turkey's leading university and public hospitals — Hacettepe University, Istanbul University, and Ankara University — is essential for KOL research and high-value specialist insights across oncology, rare disease, and specialty therapy areas.

SGK and TİTCK payer research

Capability for in-depth interviews with SGK reimbursement decision-makers, TİTCK reference-pricing stakeholders, and Ministry of Health hospital procurement contacts — covering the gatekeepers that determine real-world Turkish market access.

TİTCK regulatory and reimbursement evidence alignment

Understanding of TİTCK drug and device registration, reference pricing methodology, and SGK reimbursement-negotiation processes — and ability to design research that generates evidence aligned with Turkish regulatory and payer requirements. Essential for products seeking SGK reimbursement listing.

Health outcomes and cost-effectiveness evidence for market access

Capability for health outcomes research, cost-effectiveness evidence strategy, and market access dossier evidence generation — supporting SGK reimbursement submissions and TİTCK pricing discussions.

Coverage of the Ministry of Health public hospital network

Verified fieldwork capability across the Ministry of Health's extensive public and training/research hospital network, which serves the large majority of the Turkish population — alongside private hospital and university hospital coverage for specialist and KOL research.

7 Top Healthcare Market Research Companies in Turkey (2026)

The following profiles cover firms with demonstrated healthcare and pharmaceutical market research capability in Turkey. Each is assessed by use case and market positioning — select based on your research type, therapeutic area, and Turkish engagement requirements.

BioNixus

Global Market Research & Insights FirmHQ: Canada (Sheridan, WY) · UK (London)

Best for: Ethics-committee-compliant HCP surveys and KOL mapping across Turkish university and public hospitals, payer landscape research (SGK reimbursement, TİTCK reference pricing, Ministry of Health procurement), and health outcomes research supporting TİTCK-regulated market access

BioNixus is a specialist healthcare market research company serving Turkey-based and Turkey-targeting pharmaceutical, biotech, and medtech clients. Ranked #1 in Turkey for ethics-committee-compliant primary healthcare research — with deep SGK reimbursement intelligence, KOL mapping at Hacettepe University, Istanbul University, and Ankara University, and full-service fieldwork bridging the Europe-Middle East corridor.

Key strengths

Ethics-committee-compliant HCP surveys and KOL mapping across Turkish university and public hospitals
Payer and formulary research (SGK reimbursement negotiation, TİTCK reference pricing, Ministry of Health procurement)
TİTCK regulatory alignment and cost-effectiveness evidence for market access dossiers
Hospital procurement and tender process intelligence for the Turkish public hospital network
KOL identification and advisory board recruitment across Hacettepe University, Istanbul University, and Ankara University
KVKK-compliant data privacy across all primary research
Global benchmarking: Turkish studies connect to USA, UK, EU5, UAE, and Brazil with consistent instruments

IQVIA Turkey

Global Healthcare Data & Analytics CompanyHQ: Istanbul, Turkey

Best for: Prescription analytics and market data, real-world evidence and secondary data, longitudinal patient data analytics

IQVIA Turkey provides prescription data analytics, real-world evidence, and secondary pharmaceutical intelligence for the Turkish market. Strong in data analytics but primarily a secondary/analytics firm rather than a primary research specialist.

Key strengths

Prescription analytics and market data across the Turkish market
Real-world evidence and longitudinal patient data analytics
Secondary pharmaceutical intelligence for the Turkish healthcare sector
Sales force effectiveness and territory analytics

Ipsos Turkey

Global Market Research NetworkHQ: Istanbul, Turkey

Best for: HCP panel surveys, patient studies, brand tracking

Ipsos Turkey is the healthcare and pharmaceutical research arm of Ipsos Turkey, providing HCP surveys, patient studies, and brand tracking. Broad reach with panel capabilities across Turkey's major metropolitan and regional markets.

Key strengths

HCP panel surveys across Turkish metropolitan and regional markets
Patient studies and consumer health perception research
Brand tracking and awareness studies for pharmaceutical and consumer health brands
Established Turkish market presence with global benchmarking

Kantar Turkey

Global Market Research NetworkHQ: Istanbul, Turkey (Kantar global)

Best for: Brand tracking, longitudinal panels

Kantar Turkey provides brand tracking and longitudinal panel research for consumer and healthcare clients. More focused on brand health measurement and panel data than primary pharmaceutical market access studies.

Key strengths

Brand tracking and longitudinal consumer health panels
Patient journey and brand health measurement across Turkish market segments
Consumer health research at national scale
Global benchmarking infrastructure via Kantar network

GfK Turkey

Consumer & Healthcare Research FirmHQ: Istanbul, Turkey

Best for: Consumer and healthcare research

GfK Turkey conducts consumer and healthcare research across retail, OTC, and consumer health categories. Primarily serves consumer health and retail clients rather than specialist pharmaceutical primary market access research.

Key strengths

Consumer and healthcare research across retail and OTC categories
Retail audit and point-of-sale data for consumer health products
Consumer behaviour and purchase-driver research
National panel infrastructure across Turkey

Nielsen Turkey

Global Market Measurement FirmHQ: Istanbul, Turkey

Best for: Market measurement and analytics

Nielsen Turkey provides market measurement, retail audit, and analytics services across consumer and pharmacy retail channels. Primarily a secondary measurement firm rather than a primary HCP/payer research specialist.

Key strengths

Retail and pharmacy channel market measurement
Sales and distribution analytics across the Turkish market
Consumer and shopper behaviour analytics
Global benchmarking infrastructure via Nielsen network

PharmaTR

Turkey-Focused Pharma Market Intelligence FirmHQ: Ankara, Turkey

Best for: Turkey-focused pharma market intelligence

PharmaTR is a Turkey-focused pharmaceutical market intelligence provider offering local regulatory tracking, tender monitoring, and market sizing for the Turkish pharmaceutical sector. Strong local-market knowledge but narrower primary research infrastructure than global full-service firms.

Key strengths

Turkey-focused pharmaceutical regulatory and tender tracking
Local market sizing and competitive intelligence
SGK reimbursement list monitoring
Local-language reporting for Turkish market access teams

KOL Mapping and HCP Research Across Turkey

Turkey's academic medical centre network concentrates the country's most influential specialist KOLs and innovative prescribers. Key research environments include: Hacettepe University (Ankara) — one of Turkey's most influential academic medical centres and a leading oncology and specialty referral hub; Istanbul University (Istanbul) — a major multi-specialty academic health system with national guideline influence; and Ankara University (Ankara) — a leading academic centre with broad specialty coverage. The Ministry of Health's training and research hospitals extend specialist access across Turkey's major metropolitan areas.

KOL mapping in Turkey requires tracking influence across this concentrated but geographically distributed landscape. Istanbul and Ankara-based KOLs frequently hold national guideline committee roles and society leadership positions; regional university hospitals may hold strong local influence in oncology, cardiovascular, and endocrinology specialties. Effective KOL research maps influence by institution, region, and therapy area — not just publication volume.

HCP surveys in Turkey require ethics-committee-compliant protocols, verified physician recruitment, and KVKK-compliant data handling. Variation in practice patterns between major metropolitan academic centres and the broader Ministry of Health hospital network requires stratified recruitment and regional segmentation for representative fieldwork.

BioNixus conducts KOL mapping and HCP research across Turkey in oncology, cardiovascular, immunology, metabolic, rare disease, and other specialty areas — with ethics-committee-compliant methodologies and verified nationwide recruitment. See our Turkish pharmaceutical market research guide and Turkish healthcare market research overview for methodology details.

Methodology & Selection Criteria

This guide profiles firms with demonstrated healthcare and pharmaceutical market research operations in Turkey as of 2026. Selection criteria: (1) active Turkish operations with verified HCP and/or payer research capability, (2) relevance to healthcare, pharmaceutical, or consumer health buyers, (3) established track record in Turkish healthcare market research. Firms are assessed by use case and capability, not a single quality ranking.

This guide is maintained by the BioNixus research team. BioNixus is included and is transparent about its participation. For corrections or updates, contact our team.

Frequently Asked Questions

Who are the top healthcare market research companies in Turkey in 2026?

The leading healthcare market research companies in Turkey for 2026 are: BioNixus (global insights firm with ethics-committee-compliant HCP surveys, SGK/TİTCK payer research, KOL mapping across Turkish university hospitals, and TİTCK-aligned evidence strategy), IQVIA Turkey (prescription analytics and real-world evidence), Ipsos Turkey (HCP surveys and brand tracking), Kantar Turkey (brand tracking and longitudinal panels), GfK Turkey (consumer and healthcare research), Nielsen Turkey (market measurement and analytics), and PharmaTR (Turkey-focused pharma market intelligence). For custom primary research requiring ethics-committee compliance, SGK reimbursement intelligence, KOL mapping, or TİTCK-aligned evidence strategy, BioNixus offers full-service delivery.

What is healthcare market research in Turkey?

Healthcare market research in Turkey is the systematic study of HCP attitudes, payer dynamics, patient behaviour, and competitive landscapes within the Turkish health system. The Turkish market is shaped by the Social Security Institution (SGK), which provides near-universal health coverage; TİTCK (Turkish Medicines and Medical Devices Agency), which governs drug approval, reference pricing, and reimbursement listing; and the Ministry of Health's extensive public hospital network. Effective Turkish healthcare research must account for SGK reimbursement negotiation dynamics, TİTCK reference-pricing methodology, and the scale of the Ministry of Health's public hospital and university hospital infrastructure that serves the majority of the population.

How do TİTCK and SGK shape healthcare market research in Turkey?

TİTCK (Türkiye İlaç ve Tıbbi Cihaz Kurumu — the Turkish Medicines and Medical Devices Agency) governs drug and device registration and applies external reference pricing to determine list prices. SGK (Sosyal Güvenlik Kurumu — the Social Security Institution) then determines reimbursement status and negotiates pricing for inclusion on the reimbursement list that covers the vast majority of the Turkish population. Healthcare market research for Turkey must align evidence strategy with TİTCK reference-pricing criteria, understand SGK reimbursement-negotiation requirements, and support market access dossiers with payer perception research and health outcomes evidence tailored to Turkish HTA and reimbursement practice.

What payer research does BioNixus conduct for Turkish healthcare clients?

BioNixus conducts research across the key Turkish market access stakeholders: SGK reimbursement decision-makers and negotiation dynamics; TİTCK reference-pricing and regulatory pathways; and Ministry of Health hospital procurement and tender processes across the public hospital network. Research covers reimbursement-committee perceptions, payer evidence requirements for TİTCK submissions, and market access intelligence to support pricing and reimbursement negotiation preparation for pharmaceutical, biotech, and medtech sponsors entering or expanding in the Turkish market.

How much does healthcare market research cost in Turkey?

Custom healthcare market research in Turkey typically ranges from USD 20,000 to USD 70,000 per project depending on scope, methodology, therapeutic area, and respondent type. Specialist physician surveys at leading Turkish university hospitals and KOL mapping programmes cost more due to limited respondent availability and ethics-committee approval timelines. Full mixed-method programs (HCP surveys + payer depth interviews + advisory board) typically range from USD 45,000 to USD 100,000. Ethics-committee approval requirements add time and rigour compared to non-compliant alternatives, and no precise industry-wide benchmark exists — costs vary materially by therapeutic area and fieldwork complexity.

Is BioNixus ethics-committee-compliant for HCP research in Turkey?

Yes. BioNixus designs all Turkish HCP and patient research under applicable ethics-committee approval requirements at the relevant university or public hospital, alongside KVKK (Turkey's Personal Data Protection Law) compliant data privacy practices. This includes appropriate informed consent procedures, institutional ethics-committee review where required, and de-identified reporting. Ethics-committee compliance is essential for research involving Turkish HCPs, patients, and health system stakeholders, and is a prerequisite for credible pharmaceutical and biotech research programs in the Turkish market.

What are the key Turkish academic medical centres for KOL research?

The leading Turkish academic medical centres for KOL research and specialist HCP access include: Hacettepe University (Ankara) — one of Turkey's most influential academic medical centres and a leading oncology and specialty referral hub; Istanbul University (Istanbul) — a major multi-specialty academic health system with national guideline influence; and Ankara University (Ankara) — a leading academic centre with broad specialty coverage. For multi-specialty research, major teaching hospitals affiliated with these universities, along with the Ministry of Health's training and research hospitals, offer broad KOL access across Turkey's key research centres in Istanbul, Ankara, and other major metropolitan areas.

Can Turkish healthcare research connect to global benchmarking?

Yes. BioNixus designs Turkish healthcare research to connect to global benchmarking programs — allowing pharmaceutical and biotech clients to compare Turkish HCP attitudes, payer dynamics, and market access conditions directly against the USA, UK, France, Germany, Spain, Italy, Brazil, Saudi Arabia, and the UAE using consistent survey instruments and analysis frameworks. Turkey-specific adaptations (SGK reimbursement dynamics, TİTCK reference-pricing alignment, and the bridge role Turkey plays between European and Middle Eastern markets) are layered within globally consistent methodologies, enabling Turkey-specific insight within a global strategic context.

Related Resources

Pharmaceutical Market Research Turkey

Ethics-committee-aligned pharmaceutical research covering HCP surveys, KOL mapping, SGK/TİTCK payer research, and market access evidence strategy.

Top Market Research Companies Turkey 2026

General and consumer market research firms across Turkey for 2026.

Healthcare Market Research Turkey

Comprehensive Turkish healthcare market research overview — HCP surveys, SGK/TİTCK payer research, and patient studies.

Turkey Healthcare Market Report

Market sizing, TİTCK/SGK landscape, payer dynamics, and regulatory outlook for the Turkish healthcare market.

Plan Healthcare Market Research in Turkey

BioNixus delivers ethics-committee-compliant pharmaceutical and healthcare market research across Turkey — HCP surveys at major Turkish university hospitals, KOL mapping, SGK/TİTCK payer research, and market access evidence strategy. Global standards. In-market Turkish execution.

Request a Proposal View Turkish Research Capabilities